CD30
耐火材料(行星科学)
抗体
淋巴瘤
医学
抗体疗法
免疫学
癌症研究
生物
单克隆抗体
天体生物学
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2022-04-11
卷期号:12 (6): 1401-1402
被引量:5
标识
DOI:10.1158/2159-8290.cd-nb2022-0027
摘要
According to preliminary results from a phase I/II trial, cord blood-derived natural killer cells complexed with AFM13, a bispecific antibody, showed efficacy in patients with relapsed/refractory CD30+ lymphomas. Complete responses were seen, and treatment was extremely well tolerated.
科研通智能强力驱动
Strongly Powered by AbleSci AI